- The FDA approves Sorin Group's (OTC:SORJF) Memo 3D ReChord, a semi-rigid annuloplasty ring for mitral valve repair. The device incorporates a chordal guide system into the ring to simplify and standardize the approach to artificial chord replacement. It was CE Mark approved in Europe in October.